Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis

被引:99
|
作者
Scharl, Michael [1 ,2 ]
Huber, Nicole [1 ]
Lang, Silvia [1 ]
Fuerst, Alois [3 ]
Jehle, Ekkehard [4 ]
Rogler, Gerhard [1 ,2 ]
机构
[1] Univ Zurich Hosp, Div Gastroenterol & Hepatol, Ramistr 100, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland
[3] Caritas Hosp St Josef, Dept Surg, Regensburg, Germany
[4] Oberschwaben Klin, Dept Surg, Ravensburg, Germany
来源
基金
瑞士国家科学基金会;
关键词
Crohn's disease; Epithelial-mesenchymal transition; Intestinal fibrosis;
D O I
10.1186/s40169-015-0046-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Intestinal fibrosis and subsequent stricture formation represent frequent complications of Crohn's disease (CD). In many organs, fibrosis develops as a result of epithelial to mesenchymal transition (EMT). Recent studies suggested that EMT could be involved in intestinal fibrosis as a result of chronic inflammation. Here, we investigated whether EMT might be involved in stricture formation in CD patients. Methods: Human colonic tissue specimens from fibrotic areas of 18 CD and 10 non-IBD control patients were studied. Immunohistochemical staining of CD68 (marker for monocytes/macrophages), transforming growth factor-beta(1) (TGF beta(1)), beta-catenin, SLUG, E-.cadherin, alpha-smooth muscle actin and fibroblast activation protein (FAP) were performed using standard techniques. Results: In fibrotic areas in the intestine of CD patients, a large number of CD68-positive mononuclear cells was detectable suggesting an inflammatory character of the fibrosis. We found stronger expression of TGF beta(1), the most powerful driving force for EMT, in and around the fibrotic lesions of CD patients than in non-IBD control patients. In CD patients membrane staining of beta-catenin was generally weaker than in control patients and more cells featured nuclear staining indicating transcriptionally active beta-catenin, in fibrotic areas. In these regions we also detected nuclear localisation of the transcription factor, SLUG, which has also been implicated in EMT pathogenesis. Adjacent to the fibrotic tissue regions, we observed high levels of FAP, a marker of reactive fibroblasts. Conclusions: We demonstrate the presence of EMT-associated molecules in fibrotic lesions of CD patients. These findings support the hypothesis that EMT might play a role for the development of CD-associated intestinal fibrosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Epithelial-mesenchymal transition in Crohn's disease
    Jiang, H.
    Shen, J.
    Ran, Z.
    MUCOSAL IMMUNOLOGY, 2018, 11 (02) : 294 - 303
  • [2] MiR-21 regulates epithelial-mesenchymal transition in intestinal fibrosis of Crohn?s disease by targeting PTEN/mTOR
    Wang, Zhizhi
    Zhou, Huihui
    Cheng, Fei
    Zhang, Zhendong
    Long, Shunhua
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (10) : 1358 - 1366
  • [3] Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition
    Macias-Ceja, Dulce C.
    Mendoza-Ballesteros, M. Teresa
    Ortega-Albiach, Maria
    Barrachina, M. Dolores
    Ortiz-Masia, Dolores
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [4] Notch Pathway-Mediated epithelial-mesenchymal transition and Fibrosis in Complicated Crohn's Disease
    Patel, J.
    Cejudo-Garces, A.
    Jaren, A.
    Macias-Ceja, D. C.
    Manresa, M.
    Lopez, A.
    Cosin-Roger, J.
    Calatayud, S.
    Barrachina, M. D.
    Ortiz-Masia, D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i623 - i624
  • [5] A MODEL TO STUDY INTESTINAL FIBROSIS IN IPSCDERIVED HUMAN EPITHELIAL AND MESENCHYMAL CELLS FROM CROHN'S DISEASE PATIENTS
    Valencia, Christian Wong
    Bay, Olivia
    Patel, Shachi
    Estrada, Hannah
    Casero, David
    Targan, Stephan
    Barrett, Robert
    GASTROENTEROLOGY, 2024, 166 (03) : S77 - S77
  • [6] LIPIDS DRIVE EPITHELIAL-MESENCHYMAL TRANSITION THROUGH THE ACTIVATION OF S1PR3 SIGNALING EXACERBATING INTESTINAL FIBROSIS IN CROHN'S DISEASE
    Rizzo, Giulia
    Chavez, Samuel E. Pineda
    Wozny, Marek
    Mori, Giada
    Carriles, Alejandra A.
    Ghisletti, Serena Maria Luisa
    Gandolfi, Francesco
    Vallelonga, Veronica
    Paulis, Marianna
    La Grua, Angela
    Lovisa, Sara
    Mazzarelli, Evelyn
    Loy, Laura
    Bezzio, Cristina
    Spaggiari, Paola
    Dal Buono, Arianna
    Gabbiadini, Roberto
    Carvello, Michele
    Spinelli, Antonino
    Repici, Alessandro
    Armuzzi, Alessandro
    Vetrano, Stefania
    GASTROENTEROLOGY, 2024, 166 (05) : S1272 - S1272
  • [7] A MODEL TO STUDY INTESTINAL FIBROSIS IN IPSC-DERIVED HUMAN EPITHELIAL AND MESENCHYMAL CELLS FROM CROHN'S DISEASE PATIENTS
    Valencia, Christian Wong
    Bay, Olivia
    Patel, Shachi
    Estrada, Hannah
    Casero, David
    Targan, Stephan
    Barrett, Robert
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S57 - S57
  • [8] A MODEL TO STUDY INTESTINAL FIBROSIS IN IPSC-DERIVED HUMAN EPITHELIAL AND MESENCHYMAL CELLS FROM CROHN'S DISEASE PATIENTS
    Valencia, Christian E. Wong
    Bay, Olivia K.
    Patel, Shachi
    Lu, Cheng-Hsiang
    Estrada, Hannah Q.
    Casero, David
    Targan, Stephan
    Barrett, Robert J.
    GASTROENTEROLOGY, 2024, 166 (05) : S1272 - S1272
  • [9] Evidence for a Role of Epithelial Mesenchymal Transition During Pathogenesis of Fistulae in Crohn's Disease
    Bataille, Frauke
    Rohrmeier, Christian
    Bates, Richard
    Weber, Achim
    Rieder, Florian
    Brenmoehl, Julia
    Strauch, Ulrike
    Farkas, Stefan
    Fuerst, Alois
    Hofstaedter, Ferdinand
    Schoelmerich, Juergen
    Herfarth, Hans
    Rogler, Gerhard
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (11) : 1514 - 1527
  • [10] The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis
    Biancheri, Paolo
    Pender, Sylvia L. F.
    Ammoscato, Francesca
    Giuffrida, Paolo
    Sampietro, Gianluca
    Ardizzone, Sandro
    Ghanbari, Amir
    Curciarello, Renata
    Pasini, Alessandra
    Monteleone, Giovanni
    Corazza, Gino R.
    MacDonald, Thomas T.
    Di Sabatino, Antonio
    FIBROGENESIS & TISSUE REPAIR, 2013, 6